Literature DB >> 7398602

Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects.

R J Höppener, A Kuyer, J W Meijer, J Hulsman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398602     DOI: 10.1111/j.1528-1157.1980.tb04081.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


× No keyword cloud information.
  29 in total

1.  Cerebral effects of carbamazepine capsules and Divitabs in psychiatric patients.

Authors:  A J Loonen; C H Doorschot; L P Van Bavel; B Groot; H J De Blok; L J Krijgsman; P H Van Dongen; A A Jaspers; L C Vanbrabant
Journal:  Pharm Weekbl Sci       Date:  1991-02-22

2.  The adverse event profile of pregabalin across different disorders: a meta-analysis.

Authors:  Gaetano Zaccara; Piero Perucca; Pier Franco Gangemi
Journal:  Eur J Clin Pharmacol       Date:  2012-01-21       Impact factor: 2.953

3.  Simulated fluctuations in plasma drug concentrations for patients receiving oxcarbazepine or carbamazepine extended-release capsules.

Authors:  Alaa Ahmad; William R Garnett
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

4.  Successful strategy to improve the specificity of electronic statin-drug interaction alerts.

Authors:  Hanna Marita Seidling; Caroline Henrike Storch; Thilo Bertsche; Christian Senger; Jens Kaltschmidt; Ingeborg Walter-Sack; Walter Emil Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2009-07-30       Impact factor: 2.953

5.  Extended-release formulations of antiepileptic drugs: rationale and comparative value.

Authors:  Emilio Perucca
Journal:  Epilepsy Curr       Date:  2009 Nov-Dec       Impact factor: 7.500

6.  Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets.

Authors:  Laszlo Tothfalusi; Szilvia Speidl; Laszlo Endrenyi
Journal:  Br J Clin Pharmacol       Date:  2007-08-15       Impact factor: 4.335

7.  Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.

Authors:  R Riva; M Contin; F Albani; E Perucca; G Procaccianti; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update.

Authors:  L Bertilsson; T Tomson
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

9.  Monotherapy with conventional and controlled-release carbamazepine: a double-blind, double-dummy comparison in epileptic patients.

Authors:  P J McKee; J Blacklaw; E Butler; R A Gillham; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

10.  Carbamazepine extended-release capsules in bipolar disorder.

Authors:  Richard H Weisler
Journal:  Neuropsychiatr Dis Treat       Date:  2006-03       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.